Diamonds and Dogs
10/28/14
Receptos Inc. (RCPT)Receptos Inc. is making its investors happy today, up 37.50% to $93.14. The biopharmaceutical company saw its shares soar after its bowel-disease drug succeeded in its mid-stage trial. RPC1063 had proven significantly better than a placebo in patients with ulcerative colitis (UC), a disease involving inflammation and ulcers in the colon. 58% of the patients had a positive response to the drug and 16% were in clinical remission. Shares of Receptos hit a new 52-week high of $102.60 intraday.
Twitter Inc. (TWTR)
Twitter is getting negative tweets today, down 8.62% to $44.38. The social media company saw its shares fall after missing on earnings. For the quarter, management announced a large increase in revenue; up 114% to $361.3 million. However, the large increase was not enough to cover their massive costs and expenses of $510.8 million, causing the company to be in the red for the quarter. Furthermore, Twitter's user growth slowed by nearly 2% quarter over quarter causing concerns about future user growth.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.